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Objective: Imaging of (peri)articular structures and inﬂammation with Ultrasonography (US) during the
course of osteoarthritis (OA) might contribute to knowledge about early diagnosis of OA, prognosis and
possibly the effect of disease modifying drugs. Our goal was to identify the prevalence of distinct patterns
(stable vs ﬂuctuating) in a set of US features in a cohort of patients receiving standard multimodal
treatment for knee OA at T ¼ 0, T ¼ 3 months and T ¼ 12 months.
Design: This was a prospective, explorative study including 55 patients fulﬁlling the American College of
Rheumatology clinical criteria for knee OA. Six US features were investigated including: effusion, synovial
proliferation, infrapatellar bursitis, meniscal protrusion, Baker's cyst and cartilage thickness at three time
points during 1 year. A composite inﬂammatory score was composed. Overall prevalence was assessed as
well as individual patterns which were appointed as stable or unstable.
Results: Inﬂammation like effusion and synovial hypertrophy does occur in over 40% of patients at some
time in the year of follow up and shows a ﬂuctuating pattern. Meniscal protrusion and Baker's cyst
however are more stable features.
Conclusions: Our study gives insight in the prevalence and course of US abnormalities in patients with
knee OA and contributes to the knowledge on the possible role of this imaging modality in research.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a common joint disorder, with the knee
being one of the most frequently involved sites. It is characterized
by degradation of cartilage and other (peri)articular structures and
causes pain and stiffness, which can lead to considerable disability
and in turn to decrease of quality of life and work impairment1,2.
So far no disease modifying drugs for OA are available, mainly
due to the fact that pathophysiology and relation with subsequent
signs and symptoms are not completely understood. OA is not
merely a disease of bone and cartilage but it affects the entire joint
including soft tissue structures like menisci and synovium3. Visu-
alizing these (peri)articular structures during the course of OAo: K. Bevers, Department of
, 6500 GM Nijmegen, The
.
(K. Bevers), J.W.J.Bijlsma@
skliniek.nl (J.E. Vriezekolk),
en Ende), A.denBroeder@
ternational. Published by Elsevier Lmight contribute to knowledge about early diagnosis of OA and
prognosis. Besides, knowledge about the natural course of the
disease through imaging might contribute to evaluating the effect
of possible disease modifying drugs4.
Among the available imaging tools in OA, Ultrasonography (US)
has a very attractive proﬁle. It is, in contrast to conventional radi-
ography, able to visualize (peri)articular soft tissue structures. In
addition, US in knee OA has shown good construct validity5,6 and
moderate to good interobserver reliability7,8. Compared to Mag-
netic Resonance Imaging (MRI) which also produces images of soft
tissue structures, it is relatively safe, inexpensive and less time
consuming.
Prior research focussed mainly on cross sectional associations
of US abnormalities with knee pain or progression to knee
replacement9e14. Little is known however, about the course of soft
tissue pathology visualized by US in time and thus about the
course and behaviour of soft tissue structures in the osteoarthritic
knee5. In theory, inﬂammatory aspects like effusion and synovial
proliferation are likely to ﬂuctuate in time. Mechanical features
(e.g., meniscal protrusion), however, are expected to be more
permanent and progress over time. This is of importance, becausetd. All rights reserved.
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term prediction. The limited number of previous US follow up
studies suggest that Baker's cyst is a relatively stable feature
which tends to persist up till 3 years whereas synovial effusion is
more momentary and tends to diminish 6 months after hyaluronic
acid injection15e17. Evidence from MRI studies shows a very
gradual decrease in cartilage thickness and increase in meniscal
pathology over time with follow up data up till 36 months18,19.
Little is known about the follow up of inﬂammatory changes on
MRI in knee OA20.
Therefore, in this explorative study we assessed a set of US
features in the course of time in order to identify the ones which
might be more eligible candidates for long term prediction. Our
goal was to identify the prevalence of distinct patterns (stable vs
ﬂuctuating) in a set of US features in a cohort of patients receiving
standard multimodal treatment for knee OA at T ¼ 0, T ¼ 3 months
and T ¼ 12 months.Patients and methods
Study design
This prospective, study was carried out in the framework of a
specialized knee- and hip-OA outpatient clinic. All patients were
treated according to a multimodal treatment protocol comprising
education, physical therapy, step up analgesics (acetaminophen,
non steroidal anti-inﬂammatory drugs (NSAID), tramadol) and
intra-articular injection with triamcinolonacetate and advice on
weight reduction if indicated21. In this protocol, patients were fol-
lowed up every 4weeks in the ﬁrst 3months, after that, out-patient
visits were planned yearly. The local Medical Research Ethics
Committee, region Arnhem-Nijmegen (The Netherlands) approved
the study design (study number 2009/095).Patients
A total of 55 consecutive consenting patients fulﬁlling the
American College of Rheumatology clinical criteria for knee OA1
were included in our study. The symptomatic knee was appointed
as index joint. If patients had bilateral knee OA the most symp-
tomatic kneewas selected. Exclusion criteriawere: other rheumatic
or severe orthopaedic diseases leading to inﬂammatory arthritis or
secondary OA, co-morbidity exceeding the complaints or limita-
tions of the knee OA, orthopaedic procedures planned within the
next 3 months and cognitive or sensorimotor problems interfering
with ﬁlling out questionnaires.Fig. 1. Meniscal protrusion (M). Measured between the medial collateral ligament
(MCL) and the joint space (dashed line).Data acquisition
On inclusion knee X-rays were collected. Weight bearing ﬁxed
ﬂexion posterioreanterior radiographs were graded using Kellgren
and Lawrence systematics (K&L)1. The patient was in standing
position, knee ﬂexed in 20e30, and feet internal rotated 10. At
three time points (T0 ¼ inclusion, T1 ¼ 3 months, T2 ¼ 12 months),
the US investigation was performed. At baseline clinical, de-
mographic data and data on pain and analgesics were collected.
Pain was assessed using a Numerated Rating Scale (NRS) from 0 to
10. The Knee injury and Osteoarthritis Outcome Score (KOOS)
(Likert scale version)22 was used as an instrument to assess the
patients' opinion about their knee associated problems. KOOS
scores were transformed in a way that 0 indicates no complaints
and 100 indicates maximum complaints.US
US was performed by a rheumatologist (KB) and a post-doc
physician, who were trained in musculoskeletal US and previ-
ously involved in inter reader reliability research of the applied US
protocol. Both investigators performed US on T0 and T1 (evenly
distributed). For practical reasons (acceptance job offer elsewhere
second investigator) KB performed all investigations on T2. The
protocol is based on results of previous US studies (especially the
Outcome Measures in Rheumatology (OMERACT) deﬁnitions) and
pathophysiologic concepts of knee OA5,6,10,23. It focuses on two
domains, comprising inﬂammatory (synovial hypertrophy, effusion
and bursitis), and mechanical aspects (medial meniscus protrusion,
Baker's cyst and cartilage thickness). In a previous study, the pro-
tocol showed moderate to good interobserver reliability for all
items except synovial hypertrophy7. To improve our results on sy-
novial hypertrophy, we performed renewed calibration sessions in
ﬁve patients with both investigators. Thereafter, 23 patients were
blindly investigated by both assessors and interobserver agreement
was calculated, yielding a new kappa value for synovial hypertro-
phy of 0.65. Overall, we managed to improve our interobserver
agreement as new kappa values ranged from 0.59 for meniscal
protrusion to 1.00 for Baker's cyst and effusion. For cartilage
thickness, the minimal correlation coefﬁcient was 0.74 (95% con-
ﬁdence interval (CI): 0.57e0.92) with difference of 0.12 (95% CI
limits of agreement: 0.67e0.91 mm). Clinical evaluation and US
examination were obtained on the same day. The investigator
performing US was unaware of clinical and radiographic results.
The ultrasound machine used in this study was a MyLab 25 gold
(Esaote Biomedica, Genoa, Italy) with a 35 mm linear transducer
(frequency 8e15 mHz). The complete US investigation took about
10 min per patient. The US protocol comprised the following items:
(1) Effusion: a  4 mm hypoechoic or anechoic intra-articular
material that is displaceable and compressible in the supra-
patellar recess, evaluated using a longitudinal scan with the
leg in passive full extension9.
(2) Synovial hypertrophy: an abnormal hypoechoic intra-artic-
ular tissue that is nondisplaceable and poorly compressible
of 2 mm in the suprapatellar recess, measured with the leg
in full extension with a longitudinal scan9.
(3) Meniscal protrusion: protrusion of meniscal tissue out of the
joint space >3 mm from the joint line, evaluated at the
medial joint space with the knee in full extension with a
longitudinal scan (Fig. 1)10.
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(>2 mm) on both longitudinal and transverse scans with the
knee in 45 ﬂexion10.
(5) Baker's cyst: a hypo-anechoic area between the semi-
membranosus and medial gastrocnemius tendon examined
with the patient in prone position on the dorsal/medial side
of the fully extended knee applying a transverse and longi-
tudinal scan. Themaximum diameter was measured (mm) in
a transverse plane.
(6) Cartilage thickness: an anechoic bandwith sharphyperechoic
margins, measured perpendicular to the surface at the inter-
condylar notch and at the medial and lateral condyle (5 mm
just medial or lateral from the top of the condyle), with the
transducer immediately above the patella in a transverse
plane and with the knee in maximum ﬂexion. Because of the
uneven distribution of cartilage over the femoral head we
performed threemeasurements and calculated amean value.
Measurements were standardized in calibration sessions and
interobserver reliability of these measurements was accept-
able,with correlation-coefﬁcients of 0.74e0.77 (Figs. 2 and 3).
Statistical analysis
In generating descriptive statistics, means, standard deviations
and 95% CIs were computed for continuous variables. ContinuousFig. 2. Cartilage thickness medial femur condyl. * ¼ cartilage thickness.
Fig. 3. Cartilage thickness intercondylar notch. * ¼ cartilage thickness.baseline data were checked for skewness. For dichotomous vari-
ables frequencies and 95% CIs according to the adjusted Wald
method24 were computed.
To examine the change of prevalence rates of US features in time
we used McNemar test for categorical variables and paired t test for
continuous variables, where appropriate. As effusion and synovial
proliferation are considered to be expressions of the same patho-
physiologic process, a composite inﬂammatory score was created
which was considered to be positive if effusion and/or synovial
proliferation were present at one time point. The course of US pa-
thology with dichotomous outcome measures was described using
distinct patterns. Because there are three dichotomous measure-
ments in time, there are eight possible US patterns conceivable.
Since we were interested in the stability of these features in time,
we divided these patterns into stable and unstable (e.g., ﬂuctuating
or not). We appointed two patterns as stable (present (1,1,1) or
absent (0,0,0) on all time-points). The six other patterns were
appointed unstable inwhich two are arising/increasing (0,0,1/0,1,1),
two are diminishing/disappearing (1,1,0/1,0,0) and two are random
(0,1,0/1,0,1). To describe the individualized course of cartilage
thickness, we calculated the proportion of patients which showed
decrease or increase in two time frames (T0eT1 and T0eT2). Sta-
tistical analysis was performed using the statistical software
package Stata10 (StataCorp, Texas, USA).
Results
Study population
Baseline characteristics are displayed in Table I, revealing a
typical knee OA cohort with predominantly womenwith moderate
type OA according to radiographic K&L score.
Prevalence of US pathology/US patterns
The overall prevalence of US abnormalities in time is shown in
Table II. Meniscal protrusion and Bakers' cyst were common,
whereas infrapatellar bursitis was rather rare. Most of the variation
in prevalence of US features on a group level appeared in the in-
ﬂammatory components (i.e., synovial hypertrophy and effusion).
Synovial hypertrophy and the composite inﬂammatory score
decreased signiﬁcantly from T0eT2 (P-value 0.02 and <0.01
respectively). For presence of Baker's cyst, meniscal protrusion and
infrapatellar bursitis, there is no signiﬁcant change in the course ofTable I
Baseline characteristics study population at inclusion
Patients (n) 55
Female (n, %) 35 (64)
Age (years) (mean, SD) 57 ± 8
BMI (kg/m2) (mean, SD) 29 ± 7
K&L score
0 (n, %) 7 (13)
I (n, %) 16 (29)
II (n, %) 17 (30)
III (n, %) 12 (22)
IV (n, %) 3 (6)
*NRS pain (mean, SD)(range) 5.9 ± 1.6 (2e9)
yKOOS (mean, SD)(range)
ADL 48 ± 20 (2e100)
Pain 54 ± 17 (14e100)
NSAID users (n, %) 20 (36)
40 mg of intra-articular triamcinolonacetate (n, %) 29 (53)
* NRS: 0e10 in which 0 indicates no complaints and 10 indicates maximal
complaints.
y KOOS: function in daily living/pain: normalized data (0e100) in which 0 in-
dicates no complaints and 100 indicates maximal complaints.
Table II
Overall prevalence of US abnormalities at three time-points: T0: inclusion, T1: 3
months, T2: 12 months
T0 (n ¼ 55) T1 (n ¼ 49) T2 (n ¼ 55)
Effusion
n (%, 95% CI)
8 (15, 7e26) 7 (14, 6e24) 5 (9, 4e20)
Synovial
hypertrophy
n (%, 95% CI)
9 (16, 9e28) 3 (6, 1e15) 1 (2, 0e11)
*Composite
inﬂammation
n (%, 95% CI)
17 (31, 20e44) 9 (18, 9e28) 6 (11, 5e22)
Meniscal
protrusion
n (%, 95% CI)
36 (65, 52e77) 34 (69, 50e75) 38 (69, 56e80)
Infrapatellar
bursitis
n (%, 95% CI)
5 (9, 4e20) 2 (4, 3e13) 4 (7, 2e18)
Baker's cyst
n (%, 95% CI)
19 (35, 23e48) 21 (43, 26e51) 22 (40, 28e53)
Cartilage thickness (mm) mean, SD (95% CI)
Medial epicondyl 1.6 ± 0.5 (1.4e1.7) 1.7 ± 0.5 (1.6e1.9) 1.9 ± 0.5 (1.7e2.0)
Intercondylar
notch
2.0 ± 0.5 (1.9e2.1) 2.1 ± 0.6 (2.0e2.3) 2.3 ± 0.7 (2.1e2.5)
Lateral epicondyl 1.7 ± 0.4 (1.6e1.8) 1.8 ± 0.4 (1.7e2.0) 2.0 ± 0.5 (1.9e2.1)
* Effusion and/or synovial proliferation.
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from baseline to 12 months; differences are 0.35 mm, 0.29 mm and
0.28 mm (P < 0.05) for the three locations, respectively.
In Table III the course of prevalence of US pathology in time is
shown in more detail for each US feature. 0 denotes absent, 1 de-
notes present. Of the eight conceived patterns, a and b are stable
(marked in grey). The other patterns are unstable.
Nearly half of the patients (43%) shows any sign of inﬂammation
(i.e., synovial hypertrophy and/or effusion) during the year of
follow up. In the proportion of patients which do show inﬂam-
mation at any time point, it turns out that both effusion and sy-
novial hypertrophy are ﬂuctuating features (effusion: e, g and h
predominant patterns; synovial hypertrophy: e, f and h predomi-
nant patterns).
Infrapatellar bursitis does not occur in 84% of the patients at any
time during follow up. All patients that do develop bursitis show
instable prevalence patterns and bursitis was never consistently
present at all time points.
Meniscal protrusion occurs at any time point in over 80% of the
patients. Intermittent patterns are infrequent. Baker's cyst is a
stable feature, displaying a stable pattern in 80% of the patients. In
the remaining patients the majority of the patient develops a
Baker's cyst during follow up.Table III
Number of patients with distinct US patterns in the course of 1 year (T0,T1,T2)
US patterns T0eT1eT2 Effusion
(n, %, 95% CI)
Synovial hypertrophy
(n, %, 95% CI)
*Composite in
(n, %, 95% CI)
a.0e0e0 stable 42 (76, 64e68) 43 (78, 65e87) 28 (57, 43e70
b.1e1e1 stable 3 (6, 1e15) 0 (0, 0e8) 3 (6, 1e17)
c.0e0e1 increasing 1 (2, 0e10) 1 (1.8, 0e11) 2 (4, 0e14)
d.0e1e1 increasing 0 (0, 0e8) 0 (0, 0e8) 0 (0, 0e8)
e.1e0e0 decreasing 4 (7, 2e18) 8 (15, 7e26) 9 (18, 10e32
f.1e1e0 decreasing 0 (0, 0e8) 1 (2, 0e11) 3 (6, 1e17)
g.1e0e1 random 1 (1.8) 0 (0, 0e8) 1 (2, 0e12)
h.0e1e0 random 4 (7, 2e18) 2 (4, 0e13) 3 (6, 1e17)
Total number of patients n ¼ 55.
: stable patterns.
0 ¼ absent.
1 ¼ present.
* Effusion and/or synovial proliferation.Cartilage thickness measured by US increases in 1 year of follow
up (Table II). Post hoc, individualized analyses of the proportion of
patients with an increase in cartilage thickness showed a steady
increase in both time frames (data not shown).
Discussion
To our knowledge, this is the ﬁrst study to systematically
investigate US soft tissue abnormalities in the course of time in a
cohort of patients receiving standardizedmultimodal treatment for
knee OA.
Although supportive pharmacologic treatment was given to
this cohort, this is typical for OA patients and the cohort is
comparable with other active knee OA cohort with respect to
treatment.
We showed that the prevalence of inﬂammatory features like
effusion and synovial hypertrophy show a ﬂuctuating pattern in
time in contrast to meniscal protrusion and Baker's cyst, which are
more stable. Of all assessed US pathology, inﬂammation seems to
be the only feature that declined consistently in the year of follow
up after treatment. Because information about soft tissue structures
is likely to contribute to the body of knowledge on OA and because
of the attractive proﬁle of US (harmless, inexpensive and non time-
consuming), this study contributes to knowledge about the posi-
tioning of this tool in research on OA. Based on our results, meniscal
protrusion and Baker's cyst might be useful in studies for long term
prediction of clinical or radiological outcome, whereas effusion and
synovial hypertrophy and infrapatellar bursitis seem more
momentary phenomenon.
Comparing our results to the limited previous research available
in this ﬁeld, our study shows comparable prevalence ﬁgures on
Baker's cyst15,17. These studies also show persistent presence on US,
even after intra-articular injection/arthroscopic surgery. Our data
show comparable results to former US studies which showed
decrease of inﬂammation after intra-articular hyaluronic acid in-
jection. In a study on follow up of inﬂammation detected with US in
hand OA, a similar decline was observed after 3 months of con-
servative treatment25. The decrease in our study could very well be
a result of the natural course of the disease. It might also be a
treatment effect as all patients received standardized multimodal
treatment which included NSAID and intra-articular glucocorticoid
injection in half of the patients.
Meniscal protrusion seemed to ﬂuctuate somewhat more than
expected based on pathophysiologic concept of the nature of
meniscal protrusion and previous research which suggests gradual
increase of meniscal pathology over time18,19. Although the ma-
jority of patients show a stable pattern, a third of our patients
showed ﬂuctuation in time. One might hypothesize that it isﬂammation Meniscal protrusion
(n, %, 95% CI)
Infrapatellar bursitis
(n, %, 95% CI)
Baker's cyst
(n, %, 95% CI)
) 9 (16, 9e28) 46 (84, 72e91) 29 (53, 40e65)
27 (49, 36e62) 0 (0, 0e8) 15 (27, 17e40)
4 (7, 2e18) 3 (5, 1e15) 2 (4, 3e13)
4 (7, 2e18) 1 (2, 0e11) 2 (4, 3e13)
) 4 (7, 2e18) 4 (7, 2e18) 0 (0, 0e8)
2 (4, 3e13) 1 (2, 0e11) 1 (2, 0e11)
3 (5, 1e15) 0 (0, 0e8) 3 (5, 1e15)
2 (4, 3e13) 0 (0, 0e8) 3 (5, 1e15)
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depending on weight, effusion etc. Furthermore, comparison with
previous research is hampered by the difference in follow up time
(3 years follow up vs 1 year in our study) and difference in imaging
modality (MRI vs US).
Much to our surprise, cartilage thickness seemed to increase in
this cohort in the course of 1 year. This is contradictive with current
views that expect cartilage thickness to decrease in time, as cartilage
thickness increase has only been reported thus far after treatment
with joint distraction26, and has not been observed after conser-
vative OA treatment. However, we have no other satisfying expla-
nation for our ﬁndings. A chance ﬁnding seems unlikely because the
same signiﬁcant magnitude of change is consistently seen in all
three measured domains and between the different time points. In
recent years it has become clear that visualizing femoral cartilage
with US is known to have various difﬁculties: (1) Uneven distribu-
tion over the femoral head. (2) Positioning of the probe with
repeated measurements. (3) Loss of the sharpness of the cartilage
border in the process of degeneration, which hampers precise
measurement. (4) The alteration of aspect of the cartilage (increase
of hyperechogenicity) in the process of degeneration which should
be taken into account. Unfortunately, a lot of the detailed informa-
tion about the pitfalls (and possible solutions) on US measurement
of cartilage27,28 was not available at the time of the development of
the protocol. It is possible that our measurements do not represent
absolute cartilage thickness, but they still tell us something about
the course in time, which is what we aimed for.
We considered the possibility that a systematic error was
introduced by having all measurements on T2 performed by one
investigator and all measurement before that by two randomly
assigned investigators. The fact that results of the ﬁrst and second
time frame do not differ substantially, makes this an unlikely
explanation. In this study, cartilage thickness was not our main
focus as inﬂammation and structural changes like Baker's cyst
might be even more important features in knee OA. Cartilage
thickness, however will be subject of future US research in an
attempt to verify or falsify our current ﬁndings.
Our study has some limitations, including the limited number
of patients, length of follow up, number of US time points and the
choice of US features. A larger number of patients would have
enabled us to give more precise estimates. More frequent US
investigation could have provided more insight in how long some
abnormalities are present and if they might disappear and reap-
pear in a certain time frame. Furthermore, assessment of long
term degenerative characteristics (i.e., cartilage thickness, menis-
cal protrusion) would have beneﬁtted from more prolonged
follow-up. Concerning our US protocol, it would possibly have
been of value to include osteophytes, because US has proven to
pick up small osteophytes, which can be a very early sign of OA,
more sensitively than plain radiography. However, at the time of
the selection of the US items, no widely accepted protocol to
systematically investigate knee OA with US was available. We
chose to include mechanical features: meniscal protrusion, Baker's
cyst and cartilage and excluded osteophytes because these can be
visualized using plain radiography. We aimed for features that are
not visualized by plain radiography and focused on soft tissue
instead of bony parts.
We were aware of the fact that correlationwith MRI would have
strengthened the construct validity of our results. On the other
hand, correlation between US and MRI for the items studied in our
cohort has been investigated before and has shown satisfying re-
sults5. Secondly, we were interested in practical, feasible protocol,
with limited costs and patient burden and felt that previously
demonstrated validity of US features was sufﬁcient to address the
course in time.In conclusion, our study gives insight in the prevalence and
typical course of US abnormalities in patients with knee OA. It
shows that inﬂammation is a momentary phenomenon and can
decrease in the course of follow up and that Baker's cyst and
meniscal protrusion are stable features which possibly are more
eligible candidates for long term prediction.
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